17
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Paraoxonase Genotype, LDL-oxidation and Carotid Atherosclerosis in Male Life-long Smokers

, , , , , & show all
Pages 553-560 | Received 16 Oct 2003, Published online: 07 Jul 2009

References

  • Davies, H.G., Richter, R.J., Keifer, M., Broomfield, C.A., Sowalla, J. and Furlong, C.E. (1996) "The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin", Nat. Genet. 14, 334–336.
  • Mackness, MI., Arrol, S. and Durrington, P.N. (1991) "Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein", FEBS Lett. 286, 152–154.
  • Shih, D.M., Gu, L., Xia, YR., Navab, M., Li, WE, Hama, S., Castellani, L.W., Furlong, C.E., Costa, L.G., Fogelman, A.M. and Lusis, A.J. (1998) "Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis", Nature 394, 284–287.
  • Brophy, V.H., Jampsa, R.L., Clendenning, J.B., McKinstry, L.A., Jarvik, G.P. and Furlong, C.E. (2001) "Effects of 5 regulatory-region polymorphisms on para-oxonase-gene (PON1) expression", Am. J. Hum. Genet. 68, 1428–1436.
  • Furlong, C.E., Richter, R.J., Chapline, C. and Crabb, J.W. (1991) "Purification of rabbit and human serum para-oxonase", Biochemistry 30, 10133–10140.
  • Humbert, R., Adler, D.A., Disteche, C.M., Hassett, C., Omiecinski, C.J. and Furlong, C.E. (1993) "The molecular basis of the human serum paraoxonase activity polymorph-ism", Nat. Genet. 3, 73–76.
  • Garin, M.C., James, R.W., Dussoix, E, Blanche, H., Passa, P., Froguel, P. and Ruiz, J. (1997) "Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes", J. Clin. Investig. 99, 62–66.
  • Ruiz, J., Blanche, H., James, R.W., Garin, M.C., Vaisse, C., Charpentier, G., Cohen, N., Morabia, A., Passa, P. and Froguel, P. (1995) "Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes", Lancet 346, 869–872.
  • Sanghera, D.K., Aston, C.E., Saha, N. and Kamboh, MI. (1998) "DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease", Am. J. Hum. Genet. 62, 36–44.
  • Schmidt, H., Schmidt, R., Niederkorn, K., Gradert, A., Schumacher, M., Watzinger, N., Hartung, H.P. and Kostner, G.M. (1998) "Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study", Stroke 29, 2043–2048.
  • Serrato, M. and Marian, A.J. (1995) "A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease", J. Clin. Investig. 96, 3005–3008.
  • Zama, T., Murata, M., Matsubara, Y., Kawano, K., Aoki, N., Yoshino, H., Watanabe, G., Ishikawa, K. and Ikeda, Y. (1997) "A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese", Arterioscler Thromb. Vasc. Biol. 17, 3565–3569.
  • Antikainen, M., Murtomaki, S., Syvanne, M., Pahlman, R., Tahvanainen, E., Jauhiainen, M., Frick, M.H. and Ehnholm, C. (1996) "The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns", J. Clin. Investig. 98, 883–885.
  • Gardemarm, A., Philipp, M., Hess, K., Katz, N., Tillmanns, H. and Haberbosch, W. (2000) "The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease", Atherosclerosis 152, 421–431.
  • Hermtarm, S.M., Blanc, H., Poirier, 0., Arveiler, D., Luc, G., Evans, A., Marques-Vidal, P., Bard, J.M. and Cambien, F. (1996) "The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study", Atherosclerosis 126, 299–303.
  • Ko, Y.L., Ko, YS., Wang, S.M., Hsu, L.A., Chang, C.J., Chu, PH., Cheng, N.J., Chen, W.J., Chiang, C.W. and Lee, YS. (1998) "The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan", Atherosclerosis 141, 259–264.
  • Ombres, D., Pannitteri, G., Montali, A., Candeloro, A., Seccareccia, F., Campagna, F., Cantini, R., Campa, P.P., Ricci, G. and Arca, M. (1998) "The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients", Arterioscler Thromb. Vasc. Biol. 18, 1611–1616.
  • Sanghera, D.K., Saha, N. and Kamboh, M.I. (1998) "The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese", Atherosclerosis 136, 217–223.
  • Mackness, B., Durrington, P., McElduff, P., Yarnell, J., Azam, N., Watt, M. and Mackness, M. (2003) "Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study", Circulation 107, 2775–2779.
  • Leus, ER., Wittekoek, M.E., Prins, J., Kastelein, J.J. and Voorbij, HA. (2000) "Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia", Atherosclerosis 149, 371–377.
  • O'Leary D.H. and Polak, J.F. (2002) "Intima-media thickness: a tool for atherosclerosis imaging and event prediction", Am. J. Cardiol. 90, 18L–21L.
  • Morrow, J.D., Frei, B., Longmire, A.W., Gaziano, J.M., Lynch, S.M., Shyr, Y., Strauss, WE., Oates, J.A. and Roberts, L.J., II (1995) "Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage", N. Engl. J. Med. 332, 1198–1203.
  • Santanam, N., Sanchez, R., Hendler, S. and Parthasarathy, S. (1997) "Aqueous extracts of cigarette smoke promote the oxidation of low density lipoprotein by peroxidases", FEBS Lett. 414, 549–551.
  • De Waart, F.G., Smilde, T.J., Wollersheim, H., Stalenhoef, A.F. and Kok, F.J. (2000) "Smoking characteristics, antioxidant vitamins, and carotid artery wall thickness among life-long smokers", J. Clin. Epidemiol. 53, 707–714.
  • Smilde, T.J., Wollersheim, H., van Langen, H. and Stalenhoef, A.F. (1997) "Reproducibility of ultrasono-graphic measurements of different carotid and femoral artery segments in healthy subjects and in patients with increased intima-media thickness", Clin. Sci. (Lond.) 93, 317–324.
  • Esterbauer, H., Striegl, G., Puhl, H. and Rotheneder, M. (1989) "Continuous monitoring of in vitro oxidation of human low density lipoprotein", Free Radic. Res. Commun. 6, 67–75.
  • Princen, H.M., van Poppel, G., Vogelezang, C., Buytenhek, R. and Kok, F.J. (1992) "Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking", Arterioscler. Thromb. 12, 554–562.
  • van Tits, L.J., de Waart, F., Hak-Lemmers, H.L., van Heijst, P., de Graaf, J., Demacker, P.N. and Stalenhoef, A.F. (2001) "Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers", Free Radic. Biol. Med. 30, 1122–1129.
  • Demacker, P.N., Hijmans, A.G., Brenninkmeijer, B.J., Jansen, A.P. and van't Laar, A. (1984) "Five methods for determining low-density lipoprotein cholesterol compared", Clin. Chem. 30, 1797–1800.
  • Harats, D., Ben-Naim, M., Dabach, Y., Hollander, G., Stein, 0. and Stein, Y. (1989) "Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages", Atherosclerosis 79, 245–252.
  • Siekmeier, R., Wulfroth, P., Wieland, H., Gross, W. and Marz, W. (1996) "Low-density lipoprotein susceptibility to in vitro oxidation in healthy smokers and nonsmokers", Clin. Chem. 42, 524–530.
  • Marangon, K., Herbeth, B., Artur, Y., Esterbauer, H. and Siest, G. (1997) "Low and very low density lipoprotein composition and resistance to copper-induced oxidation are not notably modified in smokers", Clin. Chim. Acta 265, 1–12.
  • Chen, C. and Loo, G. (1995) "Cigarette smoke extract inhibits oxidative modification of low density lipoprotein", Athero-sclerosis 112, 177–185.
  • Sozmen, E.Y., Sozmen, B., Girgin, F.K., Delen, Y., Azarsiz, E., Erdener, D. and Ersoz, B. (2001) "Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation", Clin. Exp. Med. 1, 195–199.
  • Cao, H., Girard-Globa, A., Serusclat, A., Bernard, S., Bondon, P., Picard, S., Berthezene, F. and Moulin, P. (1998) "Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin depen-dent diabetes mellitus", Atherosclerosis 138, 361–366.
  • Sampson, M.J., Astley, S., Richardson, T., Willis, G., Davies, I.R., Hughes, D.A. and Southon, S. (2001) "Increased DNA oxidative susceptibility without increased plasma LDL oxidizability in Type II diabetes: effects of alpha-tocopherol supplementation", Clin. Sci. (Lond.) 101, 235–241.
  • James, R.W., Leviev, I. and Righetti, A. (2000) "Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease", Circulation 101, 2252–2257.
  • Abbott, C.A., Mackness, MI., Kumar, S., Boulton, A.J. and Durrington, EN. (1995) "Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipopro-teins", Arterioscler. Thromb. Vasc. Biol. 15, 1812–1818.
  • Sen-Banerjee, S., Siles, X. and Campos, H. (2000) "Tobacco smoking modifies association between Gln-Arg192 poly-morphism of human paraoxonase gene and risk of myocardial infarction", Arterioscler. Thromb. Vasc. Biol. 20, 2120–2126.
  • Salonen, J.T., Yla-Herttuala, S., Yamamoto, R., Butler, S., Korpela, H., Salonen, R., Nyyssonen, K., Palinski, W. and Witztum, J.L. (1992) "Autoantibody against oxidised LDL and progression of carotid atherosclerosis", Lancet 339, 883–887.
  • Shoji, T., Nishizawa, Y., Fukumoto, M., Shimamura, K., Kimura, J., Kanda, H., Emoto, M., Kawagishi, T. and Morii, H. (2000) "Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects", Atherosclerosis 148, 171–177.
  • Fukumoto, M., Shoji, T., Emoto, M., Kawagishi, T., Okuno, Y. and Nishizawa, Y. (2000) "Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population", Arterioscler. Thromb. Vase. Biol. 20, 703–707.
  • Lehtimaki, T., Lehtinen, S., Solakivi, T., Nikkila, M., Jaakkola, 0., Jokela, H., Yla-Herttuala, S., Luoma, J.S., Koivula, T. and Nilckari, T. (1999) "Autoantibodies against oxidized low density lipoprotein in patients with angio-graphically verified coronary artery disease", Arterioscler. Thromb. Vase. Biol. 19, 23–27.
  • Hulthe, J., Bokemark, L. and Fagerberg, B. (2001) "Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men", Arterioscler. Thromb. Vasc. Biol. 21, 101–107.
  • Boullier, A., Hamon, M., Walters-Laporte, E., Martin-Nizart, F., Mackereel, R., Fruchart, J.C., Bertrand, M. and Duriez, P. (1995) "Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease", Clin. Chim. Acta. 238, 1–10.
  • Paiker, J.E., Raal, F.J. and von Arb, M. (2000) "Auto-antibodies against oxidized LDL as a marker of coronary artery disease in patients with familial hypercholesterolaemia", Ann. Clin. Biochem. 37(Pt 2), 174–178.
  • van de Vijver, L.P., Steyger, R., van Poppel, G., Boer, J.M., Kruijssen, D.A., Seidell, J.C. and Princen, H.M. (1996) "Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls", Atherosclerosis 122, 245–253.
  • Malin, R., Knuuti, J., Janatuinen, T., Laaksonen, R., Vesalainen, R., Nuutila, P., Jokela, H., Laakso, J., Jaakkola, 0., Solakivi, T. and Lehtimaki, T. (2001) "Para-oxonase gene polymorphisms and coronary reactivity in young healthy men", J. Mol. Med. 79, 449–458.
  • Mackness, B., Mackness, MI., Arrol, S., Turkie, W. and Durrington, P.N. (1998) "Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification", FEBS Lett. 423, 57–60.
  • Howard, G., Wagenknecht, L.E., Burke, G.L., Diez-Roux, A., Evans, G.W., McGovern, P., Nieto, F.J. and Tell, G.S. (1998) "Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study", J. Am. Med. Assoc. 279, 119–124.
  • Tell, G.S., Polak, J.F., Ward, B.J., Kittner, S.J., Savage, P.J. and Robbins, J. (1994) "Relation of smoking with carotid artery wall thickness and stenosis in older adults. The Cardio-vascular Health Study. The Cardiovascular Health Study (CHS) Collaborative Research Group", Circulation 90, 2905–2908.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.